These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21462785)

  • 1. Vinflunine.
    Prescrire Int; 2011 Jan; 20(112):11-3. PubMed ID: 21462785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.
    Bellmunt J; Delgado FM; George C
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S34-43. PubMed ID: 18538178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinflunine as second-line treatment in platin-resistant metastatic urothelial carcinoma: a review.
    Gerullis H; Ecke T; Eimer C; Wishahi M; Otto T
    Anticancer Drugs; 2011 Jan; 22(1):9-17. PubMed ID: 20948429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinflunine: a fluorinated vinca alkaloid for bladder cancer therapy.
    Gerullis H
    Drugs Today (Barc); 2011 Jan; 47(1):17-25. PubMed ID: 21373647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.
    Gerullis H; Ecke TH; Janusch B; Arndt C; Heidari M; Oniani J; Otto T
    Anticancer Drugs; 2011 Oct; 22(9):940-3. PubMed ID: 21642839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vinflunine: a new microtubule inhibitor agent.
    Bennouna J; Delord JP; Campone M; Nguyen L
    Clin Cancer Res; 2008 Mar; 14(6):1625-32. PubMed ID: 18347163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vinflunine.
    Frampton JE; Moen MD
    Drugs; 2010 Jul; 70(10):1283-93. PubMed ID: 20568834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine.
    Krajewski KM; Fougeray R; Bellmunt J; Pons F; Schutz FA; Rosenberg JE; Salhi Y; Choueiri TK
    Eur J Cancer; 2012 Jul; 48(10):1495-502. PubMed ID: 22176867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy.
    Bellmunt J; Fougeray R; Rosenberg JE; von der Maase H; Schutz FA; Salhi Y; Culine S; Choueiri TK
    Ann Oncol; 2013 Jun; 24(6):1466-72. PubMed ID: 23419284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity and efficacy of vinflunine in metastatic carcinoma of the bladder after failure of adjuvant treatment: description of a clinical case].
    Morelli F
    Recenti Prog Med; 2015 Jun; 106(6):e300-5. PubMed ID: 26076423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The first Slovak experience with second-line vinflunine in advanced urothelial carcinomas.
    Palacka P; Mego M; Obertova J; Chovanec M; Sycova-Mila Z; Mardiak J
    Klin Onkol; 2014; 27(6):429-33. PubMed ID: 25493582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VICTOR: Vinflunine in advanced metastatic transitional cell carcinoma of the urothelium: A retrospective analysis of the use of vinflunine in multi-centre real life setting as second line chemotherapy through Free of Charge Programme for patients in the UK and Ireland.
    Hussain SA; Ansari J; Huddart R; Power DG; Lyons J; Wylie J; Vilarino-Varlela M; Elander NO; McMenemin R; Pickering LM; Faust G; Chauhan S; Jackson RJ
    Int J Oncol; 2017 Mar; 50(3):768-772. PubMed ID: 28098864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN).
    Bellmunt J; Kerst JM; Vázquez F; Morales-Barrera R; Grande E; Medina A; González Graguera MB; Rubio G; Anido U; Fernández Calvo O; González-Billalabeitia E; Van den Eertwegh AJM; Pujol E; Perez-Gracia JL; González Larriba JL; Collado R; Los M; Maciá S; De Wit R;
    Ann Oncol; 2017 Jul; 28(7):1517-1522. PubMed ID: 28419193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinflunine in the treatment of advanced bladder cancer.
    Mamtani R; Vaughn DJ
    Expert Rev Anticancer Ther; 2011 Jan; 11(1):13-20. PubMed ID: 21166506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice.
    Castellano D; Puente J; de Velasco G; Chirivella I; López-Criado P; Mohedano N; Fernández O; García-Carbonero I; González MB; Grande E
    BMC Cancer; 2014 Oct; 14():779. PubMed ID: 25342282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1).
    De Santis M; Wiechno PJ; Bellmunt J; Lucas C; Su WC; Albiges L; Lin CC; Senkus-Konefka E; Flechon A; Mourey L; Necchi A; Loidl WC; Retz MM; Vaissière N; Culine S
    Ann Oncol; 2016 Mar; 27(3):449-54. PubMed ID: 26673352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen.
    Culine S; Theodore C; De Santis M; Bui B; Demkow T; Lorenz J; Rolland F; Delgado FM; Longerey B; James N
    Br J Cancer; 2006 May; 94(10):1395-401. PubMed ID: 16622447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Vinflunine in Patients with Advanced Urothelial Carcinoma Refractory to Platinum-based Chemotherapy: A Prospective Pilot Study.
    Abdel-Malek R; Shohdy KS; Abbas N; Ismail M; Hamada E; Abdel-Kader Y
    Curr Drug Saf; 2019; 14(1):31-36. PubMed ID: 30277164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second-line therapy in bladder cancer.
    Bachner M; De Santis M
    Curr Opin Urol; 2009 Sep; 19(5):533-9. PubMed ID: 19550334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinflunine in Advanced Transitional Cell Cancer of the Urothelial Tract: A Potential Option for Maintenance Therapy? A Case Series.
    Palumbo R; Licata L; Sottotetti F; Tagliaferri B; Pozzi E; Teragni C; Quaquarini E; Bernardo A
    Oncol Res Treat; 2018; 41(1-2):8-13. PubMed ID: 29402855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.